MIOPIC
Financiado
Measuring Illegal Online Pharmacies' Impact and Co-evolution
The pharma analytics market reached $60B in revenues in 2021 and is expected to grow at a 20% annual rate in the coming years. The data and business intelligence provided by pharma analytics companies around drug sales is of outmo...
The pharma analytics market reached $60B in revenues in 2021 and is expected to grow at a 20% annual rate in the coming years. The data and business intelligence provided by pharma analytics companies around drug sales is of outmost importance for multiple stakeholders in the pharma industry (e.g., manufacturers, distributors, and regulators), who rely on this data for their decision-making. However, this data is becoming increasingly biased and myopic: it only accounts for drug sales from legal pharmacies, overlooking sales from illegal pharmacies. This limitation is becoming more and more problematic since sales from illegal pharmacies (mainly operating online) are growing at a substantive pace. The goal of this PoC is to address this limitation through the development of a web service that will provide data and business analytics on drug sales by Illegal Online Pharmacies (IOPs). This web service will allow potential users to visualize market trends, download data, and develop customized reports on IOPs The goal of this PoC is to develop a web service API that will provide data and business analytics on drug sales by Illegal Online Pharmacies (IOPs) through a web portal. This web service will allow potential users to visualize market trends, download data, and develop customized reports, and will be provided following a pay-per-use commercial structure. While multiple stakeholders in the pharma industry are potentially interested in this data (e.g., manufacturers, distributors, pharma analytics companies, policy-makers, and law enforcement authorities), this data is currently unavailable due to the obscure nature of IOPs’ activities. The web service proposed in this PoC will generate such data through the algorithms designed in the ILLEGALPHARMA ERC-funded project. Accordingly, this PoC outlines the technological and commercial processes that will be implemented to transform the research generated in ILLEGALPHARMA into a business innovation with market potential.
ver más
Duración del proyecto: 18 meses
Fecha Inicio: 2023-04-20
Fecha Fin: 2024-10-31
Fecha Fin: 2024-10-31
Línea de financiación: concedida
El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-04-20
HORIZON EUROPE
No se conoce la línea exacta de financiación, pero conocemos el organismo encargado de la revisión del proyecto.
Líder del proyecto
INSTITUTO DE EMPRESA
No se ha especificado una descripción o un objeto social para esta compañía.
